Ardent Health Inc.
ARDT | NYSE
$10.61
+$0.13 (+1.24%)
At close: Sep 21, 2026, 4:00 PM ET
$10.61
$0 (0.00%)
After-hours:
Sep 21, 2026, 5:05 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.41B | 6.43B | 6.32B | 6.33B | 6.2B | 6.02B | 5.97B | 5.71B | 5.63B | 5.53B | 5.41B | 4.06B | 2.69B | 1.32B |
Cost of Revenue | 4.49B | 3.23B | 2.14B | 1.86B | 1.44B | 1.42B | 1.42B | 1.37B | 1.71B | 2.05B | 1.83B | 1.23B | 632.99M | 34.7M |
Gross Profit | 1.92B | 3.2B | 4.19B | 4.47B | 4.76B | 4.6B | 4.54B | 4.34B | 3.92B | 3.48B | 3.58B | 2.83B | 2.05B | 1.28B |
Operating Income | 483.2M | 577.28M | 563.45M | 795.49M | 611.55M | 316.86M | 325.59M | 160.68M | 315.44M | 694.01M | 672.33M | 500.45M | 275.31M | 54.15M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 207.96M | 286.75M | 286.36M | 361.23M | 420.5M | 380.69M | 363.06M | 204.64M | 193.54M | 179.18M | 151.61M | 142.79M | 96.82M | 29M |
Net Income | 78.23M | 134.28M | 135.81M | 205.06M | 254.86M | 224.68M | 210.34M | 91.99M | 86.5M | 76.81M | 53.9M | 58.06M | 37.22M | 4.14M |
Selling & General & Admin | 1.02B | 2.06B | 3.06B | 3.3B | 3.63B | 3.55B | 3.49B | 3.46B | 3.04B | 2.63B | 2.57B | 1.99B | 1.43B | 885.37M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 414.23M | 563.32M | 565.14M | 369.98M | 524.45M | 732.46M | 722.68M | 722.68M | 568.21M | 157.18M | 342.77M | 342.77M | 342.77M | 342.77M |
Operating Expenses | 1.44B | 2.62B | 3.63B | 3.67B | 4.15B | 4.28B | 4.22B | 4.18B | 3.61B | 2.79B | 2.91B | 2.33B | 1.78B | 1.23B |
Interest Expense | 49.61M | 51.77M | 55.2M | 56.35M | 57.06M | 60.49M | 63.36M | 59.4M | 63.81M | 64.35M | 65.43M | 55.85M | 36.81M | 18.12M |
Selling & Marketing Expenses | 340.37M | 340.37M | 340.37M | 669.6M | 329.23M | 329.23M | 329.23M | 310.87M | 621.34M | 935.9M | 935.9M | 625.03M | 314.56M | n/a |
Cost & Expenses | 5.92B | 5.85B | 5.76B | 5.53B | 5.59B | 5.71B | 5.64B | 5.55B | 5.32B | 4.84B | 4.74B | 3.56B | 2.41B | 1.26B |
Income Tax Expense | 39.32M | 57.09M | 56.22M | 64.47M | 78.94M | 67.87M | 63.35M | 35.04M | 31.24M | 28.13M | 22.64M | 24.59M | 17.33M | 5.22M |
Shares Outstanding (Basic) | 141.69M | 141.27M | 140.76M | 140.57M | 140.22M | 140.06M | 142.75M | 137.11M | 142.76M | 143.26M | 142.11M | 140.96M | 142.76M | 143.26M |
Shares Outstanding (Diluted) | 143.05M | 141.78M | 141.45M | 141.24M | 141.11M | 140.7M | 132.75M | 137.54M | 142.76M | 143.26M | 142.11M | 140.96M | 142.76M | 143.26M |
EPS (Basic) | 0.55 | 0.95 | 0.97 | 1.45 | 1.81 | 1.59 | 1.48 | 0.63 | 0.59 | 0.52 | 0.35 | 0.41 | 0.26 | 0.03 |
EPS (Diluted) | 0.55 | 0.95 | 0.96 | 1.50 | 1.86 | 1.64 | 1.54 | 0.63 | 0.59 | 0.52 | 0.35 | 0.41 | 0.26 | 0.03 |
EBITDA | 401.7M | 505.76M | 502.01M | 551.65M | 604.5M | 565.12M | 549.5M | 416.25M | 408.28M | 383.96M | 356.83M | 294.66M | 194.16M | 81.82M |
EBIT | 237.18M | 343.27M | 346.31M | 399.12M | 454.36M | 417.99M | 403.22M | 271.83M | 265.15M | 242.47M | 215.98M | 189.8M | 124.79M | 47.12M |
Depreciation & Amortization | 164.52M | 162.49M | 155.7M | 152.52M | 150.14M | 147.14M | 146.29M | 144.42M | 143.13M | 141.49M | 140.84M | 104.86M | 69.37M | 34.7M |
Add to Watchlist
Select watchlists to add or remove ARDT